Suppr超能文献

米非司酮联合米索前列醇终止妊娠。

The combination of mifepristone and misoprostol for the termination of pregnancy.

出版信息

Int J Gynaecol Obstet. 2011 Oct;115(1):1-4. doi: 10.1016/j.ijgo.2011.07.013. Epub 2011 Aug 27.

Abstract

The combination of 200mg of mifepristone followed by 25 μg to 800 μg (depending on gestational age) of misoprostol has been shown to be effective for the termination of pregnancy throughout gestation. The dose of misoprostol should be reduced as gestational age increases. Mifepristone is not indicated for induction of labor with a live fetus because there are no data to confirm that it does not have a possible deleterious fetal effect. The course of treatment and prerequisites for medical abortion and recommended mifepristone and misoprostol regimens for different gestational ages are described, along with the side effects, management of complications, and postabortion care. The use of the mifepristone-misoprostol combination regimen for induction of labor in cases of fetal death is also described.

摘要

米非司酮联合米索前列醇(剂量取决于孕周,为 25μg 至 800μg)已被证明在整个孕期均可有效终止妊娠。随着孕周的增加,米索前列醇的剂量应减少。米非司酮不适用于活胎引产,因为没有数据证实其不会对胎儿产生潜在的有害影响。本文描述了药物流产的治疗流程和前提条件,以及不同孕周推荐的米非司酮和米索前列醇方案,还介绍了药物流产的副作用、并发症处理和流产后护理。此外,还描述了米非司酮联合米索前列醇方案在死胎引产中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验